Cite
HARVARD Citation
Gibiansky, E. et al. (2021). Population pharmacokinetic and exposure–response analyses of intravenous and subcutaneous rituximab in patients with chronic lymphocytic leukemia. CPT: pharmacometrics & systems pharmacology. pp. 914-927. [Online].